Quinidine-associated skin discoloration in KCNT1-associated pediatric epilepsy

Neurology. 2017 Nov 21;89(21):2212. doi: 10.1212/WNL.0000000000004674.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Epilepsy / drug therapy*
  • Epilepsy / genetics*
  • Humans
  • Infant
  • Male
  • Nerve Tissue Proteins / genetics*
  • Pigmentation Disorders / chemically induced*
  • Potassium Channel Blockers / adverse effects*
  • Potassium Channels / genetics*
  • Potassium Channels, Sodium-Activated
  • Quinidine / adverse effects*

Substances

  • KCNT1 protein, human
  • Nerve Tissue Proteins
  • Potassium Channel Blockers
  • Potassium Channels
  • Potassium Channels, Sodium-Activated
  • Quinidine